Barclays Portfolio holdings
Barclays is a British universal bank whose roots go back to 1690, when the Quakers John Freame and Thomas Gould started a goldsmith banking business in London. The Barclays name came into the business in 1736, when James Barclay, son-in-law of founder John Freame, became a partner. Barclays launched the UK's first credit card, Barclaycard, in 1966, and in 1967 put the world's first cash machine in a branch in Enfield. In 2008 Barclays bought the North American operations of Lehman Brothers, and in 2009 it sold its Barclays Global Investors unit, home of the iShares ETFs, to BlackRock. It runs five divisions: UK consumer banking, UK corporate banking, private banking and wealth management, an investment bank and a US consumer bank.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$17.5B |
| 2 |
NVIDIA
NVDA
|
+$2.7B |
| 3 |
Intel
INTC
|
+$1.98B |
| 4 |
Broadcom
AVGO
|
+$1.46B |
| 5 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$1.11B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$35.8B |
| 2 |
Apple
AAPL
|
+$1.83B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$913M |
| 4 |
Microsoft
MSFT
|
+$856M |
| 5 |
Bank of America
BAC
|
+$792M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 49.47% |
| 2 | Technology | 19.84% |
| 3 | Consumer Discretionary | 7.61% |
| 4 | Financials | 5.61% |
| 5 | Communication Services | 3.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
5201
Integra Resources
ITRG
$454M
| $3 | ﹤0.01% |
+1
| New | +$3 |
2026 Q3
0 quarters
|
|
5202
IZEA Worldwide
IZEA
$38.2M
| $3 | ﹤0.01% |
1
-124
| -99% | -$391 |
2026 Q2
1 quarter
|
|
5203
Lisata Therapeutics
LSTA
$11.1M
| $3 | ﹤0.01% |
2
-68
| -97% | -$127 |
2026 Q2
1 quarter
|
|
5204
Northern Dynasty Minerals
NAK
$348M
| $3 | ﹤0.01% |
2
-21,636
| -100% | -$34.2K |
2026 Q1
2 quarters
|
|
5205
Neonode
NEON
$10.5M
| $3 | ﹤0.01% |
3
-1,579
| -100% | -$1.38K |
2025 Q2
5 quarters
|
|
5206
Odyssey Marine Exploration
OMEX
$25.4M
| – | – |
-41
| Closed | -$786 | – |
|
5207
Pioneer Power Solutions
PPSI
$25.2M
| $3 | ﹤0.01% |
+1
| New | +$3 |
2026 Q3
0 quarters
|
|
5208
Smith Micro Software
SMSI
$12.6M
| $3 | ﹤0.01% |
+1
| New | +$3 |
2026 Q3
0 quarters
|
|
5209
Senti Biosciences Holdings
SNTI
$6.15M
| $3 | ﹤0.01% |
10
-758
| -99% | -$350 |
2026 Q2
1 quarter
|
|
5210
Metagenomi Therapeutics
MGX
$26.8M
| $3 | ﹤0.01% |
3
-164
| -98% | -$197 |
2026 Q2
1 quarter
|
|
5211
Logistic Properties of the Americas
LPA
$73.2M
| $3 | ﹤0.01% |
1
-402
| -100% | -$1.26K |
2025 Q2
5 quarters
|
|
5212
IP Strategy Holdings
IPST
$1.55M
| $3 | ﹤0.01% |
1
-14
| -93% | -$51 |
2026 Q2
1 quarter
|
|
5213
Reed's Inc
REED
$12M
| $3 | ﹤0.01% |
5
-53
| -91% | -$49 |
2026 Q2
1 quarter
|
|
5214
ABVC BioPharma
ABVC
$25.9M
| $2 | ﹤0.01% |
+2
| New | +$2 |
2026 Q3
0 quarters
|
|
5215
Aprea Therapeutics
APRE
$7.35M
| $2 | ﹤0.01% |
2
-471
| -100% | -$341 |
2026 Q2
1 quarter
|
|
5216
Aterian
ATER
$15.3M
| $2 | ﹤0.01% |
+4
| New | +$3 |
2026 Q3
0 quarters
|
|
5217
Auddia
AUUD
$2.79M
| $2 | ﹤0.01% |
+2
| New | +$2 |
2026 Q3
0 quarters
|
|
5218
BioVie
BIVI
$11.5M
| $2 | ﹤0.01% |
+1
| New | +$2 |
2026 Q3
0 quarters
|
|
5219
Cellectis
CLLS
$108M
| $2 | ﹤0.01% |
+1
| New | +$3 |
2026 Q3
0 quarters
|
|
5220
Dare Bioscience
DARE
$12.6M
| $2 | ﹤0.01% |
2
-246
| -99% | -$288 |
2026 Q2
1 quarter
|
|
5221
Myseum.AI Inc
MYSE
$6.55M
| $2 | ﹤0.01% |
+1
| New | +$2 |
2026 Q3
0 quarters
|
|
5222
Dolphin Entertainment
DLPN
$12.1M
| $2 | ﹤0.01% |
2
-96
| -98% | -$106 |
2026 Q2
1 quarter
|
|
|
ELME
5223
DELISTED
Elme Communities
ELME
| $2 | ﹤0.01% |
1
-5
| -83% | -$8 |
2013 Q2
53 quarters
|
|
5224
FTC Solar
FTCI
$26.9M
| $2 | ﹤0.01% |
1
-241
| -100% | -$718 |
2022 Q1
18 quarters
|
|
5225
Greenwave Technology Solutions
GWAV
$5.85M
| $2 | ﹤0.01% |
+1
| New | +$4 |
2026 Q3
0 quarters
|
|
Similar funds
Barclays's Q3 2026 Portfolio in Review
As of Q3 2026, Barclays held 5,855 positions worth $500B, down 4% from $521B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Barclays withdrew a net $19B in Q3 2026, closing 474 positions and reducing 1,494 holdings. Its most notable exit was ExxonMobil, an estimated $761M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 49% of assets, down from 55% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Barclays opened a new position in iShares Broad USD High Yield Corporate Bond ETF worth $199M.
- Barclays's largest Q3 2026 buy was iShares Broad USD High Yield Corporate Bond ETF: 5,582,517 shares worth $199M.
- Barclays added most to Tesla in Q3 2026, an estimated $17.5B increase.
- Barclays's biggest Q3 2026 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $35.8B.
- Barclays fully exited ExxonMobil in Q3 2026, selling an estimated $761M.
- Barclays's ten largest holdings make up 40% of its $500B portfolio in Q3 2026.
- Barclays opened 525 new positions and closed 474 in Q3 2026.
- Barclays's portfolio value fell 4% quarter-over-quarter to $500B.
Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.